In Vitro Activity of Cocoa Powder Extracts on Some Biomarkers Implicated in P. falciparum Malaria Pathogenesis


 Antiplasmodial activity, Cytokines, fractions, Peripheral blood mononuclear cells, Supernatants.

How to Cite

Seth Kwabena Amponsah, & Nana Nim Dwumfour. (2015). In Vitro Activity of Cocoa Powder Extracts on Some Biomarkers Implicated in P. falciparum Malaria Pathogenesis. Journal of Pharmacy and Nutrition Sciences, 5(1), 38–42.


Malaria is a public health concern in many developing countries, including Ghana, and efforts are being made to eradicate it. Extracts from natural products have been used in several malaria endemic areas for malaria prophylaxis and treatment. Natural cocoa powder has been reported to possess in vitro direct inhibitory on P. falciparum. This study investigated the effect of natural cocoa powder on inducible nitric oxide, TNF-α and IL-10, biomarkers that play different roles in malaria pathogenesis. Chloroform and ethylacetate fractions of cocoa powder were cultured together with phytohemagglutinin-stimulated peripheral blood mononuclear cells (PBMCs) for 24 hours at 37°C with 5% CO2. Cell free supernatants were harvested and assayed for iNO, TNF-α and IL-10. Inducible NO was determined by diazotization reaction developed by Griess. TNF-α and IL-10 were determined by ELISA. This study showed that TNF-α and iNO in phytohemagglutinin-stimulated PBMCs were significantly reduced by cocoa fractions (p < 0.05), but IL-10 levels did not change significantly (p > 0.05), although TNF-α is known to up-regulate IL-10.Apart from the documented direct inhibitory effect of cocoa powder on P. falciparum, it can be hypothesized that the antiplasmodial activity of unsweetened cocoa powder could also be due to its ability to significantly inhibit iNO and TNF-α, inflammatory substances implicated in severe malaria pathogenesis.


Muentener P, Schlagenhauf P, Steffen R. Imported malaria (1985-95): trends and perspectives. Bull World Health Organ 1999; 77: 560-6.

Sachs J, Malaney P. The economic and social burden of malaria. Nature 2002; 415: 680-5.

Agbenyega T, Angus B, Bedu-Addo G, et al. Plasma nitrogen oxides and blood lactate concentrations in Ghanaian children with malaria. Trans R Soc Trop Med Hyg 1997; 91: 298-302.

Burgner D, Xu W, Rockett K, et al. Inducible nitric oxide synthase polymorphism and fatal cerebral malaria. Lancet 1998; 352: 1193-4.

Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy - Review of a New Approach. Pharmacol Rev 2003; 55: 241-269.

Othoro C, Lal AA, Nahlen B, Koech D, Orago ASS, Udhayakumar V. A low interleukin-10 tumor necrosis factor- ? ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. J Infect Dis 1999; 179: 279-282.

Guardia T, Rotelli EA, Juarez AO, Pelzer LE. Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. IL Farmaco 2001; 56: 683-7.

Hammerstone JF, Lazarus SA, Schmitz HH. Procyanidin content and variation in some commonly consumed foods. J Nutr 2000; 130: 2086-2092.

Azizah AH, Ruslawati Nik MN, Tee Swee T. Extraction and characterisation of antioxidants from cocoa by-product. Food Chem 1999; 64: 199-202.

Addai FK. Natural cocoa as diet-mediated antimalarial prophylaxis. Med Hypotheses 2010; 74: 825-830.

Amponsah SK, Bugyei KA, Osei-Safo D, et al. In vitro activity of extract and fractions of natural cocoa powder on Plasmodium falciparum. J Med Food 2012; 15: 476-482.

Griess JP. Determination of nitrite and nitrate by Griess reaction. Ber Deutsch Chem Ges 1897; 12: 426.

Ohshima H, Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 1994; 305: 253-264.

Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994; 344: 721-5.

Keller CG, Kremsner PG, Hittner JB, Misukonis AM, Weinberg BJ, Perkins DJ. Elevated nitric oxide production in children with malarial anemia: Hemozoin-induced nitric oxide synthase Type 2 transcripts and nitric oxide in blood mononuclear cells. Infect Immun 2004; 72: 4868-4873.

Calamia KT. Current and future use of anti-TNF agents in the treatment of autoimmune, inflammatory disorders. Adv Exp Med Biol 2003; 528: 545-9.

Taylor PC, Williams RO, Feldmann M. Tumour necrosis factor alpha as a therapeutic target for immune-mediated inflammatory diseases. Curr Opin Biotechnol 2004; 15: 557-563.

Karunaweera ND, Grau GE., Gamage P, Carter R, Mendis KN. Dynamics of fever and serum TNF levels are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc Natl Acad Sci 1992; 89: 3200-3.

Mendis KN, Carter R. Clinical disease and pathogenesis in malaria. Parasitol Today 1995; 11: 1-16.

Park YC, Rimbach G, Saliou C, Valacchi G, Packer L. Activity of monomeric, dimeric, and trimeric flavonoids on NO production, TNF-? secretion, and NF-KB-dependent gene expression in RAW 264.7 macrophages. FEBS Lett 2000; 465: 93-7.

Kwiatkowski D, Molyneux ME, Stephens S, Curtis N, Klein N, Pointaire P, Smit M, Allan R, Brewster DR, Grau GE, Greenwood BM. Anti-TNF therapy inhibits fever in cerebral malaria. Q J Med 1993; 86: 91-8.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2015 Seth Kwabena Amponsah , Nana Nim Dwumfour